• 03/07/2023, Sophia-Antipolis, France

    Disclosure of total number of voting rights and number of shares in the capital as of February 28th, 2023

    Disclosure of total number of voting rights and number of shares in the capital as of February 28th, 2023, pursuant to article L-223-8 II of the French “code de Commerce” and 223-16 of the AMF’s General Regulations.
    Read more Download 20230307_PR_shares_votingrights_Feb2023.pdf
  • 02/28/2023, Sophia-Antipolis, France

    Median Technologies to present new and breakthrough results for its iBiopsy® Lung Cancer Screening CADe/CADx Software as Medical Device at the European Congress of Radiology, taking place March 1-5 2023 in Vienna, Austria

    New results, obtained on a very large cohort of 9,863 patients show drastically improved performance of the iBiopsy® LCS CADe/CADx Software as Medical Device (SaMD) with a sensitivity of 96.5% at a specificity of 97.2%.
    Read more Download 20230228_PR_CADeCADx_ECR_EN_Final.pdf
  • 02/27/2023, Sophia-Antipolis, France

    Median Technologies announces completion of the Q-submission phase with the FDA for its iBiopsy® Lung Cancer Screening CADe/CADx Software as Medical Device

    urther to the Q-submission phase completion, Median’s iBiopsy® LCS CADe/CADx SaMD pivotal study protocols are now finalized and ready for study execution. Median Technologies aims at starting the execution of the iBiopsy® LCS CADe/CADx SaMD pivotal studies by the end of Q2, 2023 and obtaining 510(k) clearance in the first half of 2024.
    Read more Download 20230223_PR_FDA_Qsub_EN_final.pdf
  • 02/23/2023, Sophia-Antipolis, France

    Median Technologies to participate in the Cowen’s 43rd Annual Health Care Conference

    Median Technologies (Paris: ALMDT), will be participating in the Cowen’s 43rd Annual Health Care Conference, taking place on March 6 – 8 ,2023, at the Boston Marriott Copley Place in Boston, MA, USA. Fredrik Brag, Median’s CEO and Founder will present on March 7th at 1:30 pm ET (7:30 pm CET).
    Read more Download 20230223_PR_Cowen_HCconference_EN-1.pdf
  • 02/08/2023, Sophia-Antipolis, France

    Disclosure of total number of voting rights and number of shares in the capital as of January 31st, 2023

    Disclosure of total number of voting rights and number of shares in the capital as of January 31st, 2023, pursuant to article L-223-8 II of the French “code de Commerce” and 223-16 of the AMF’s General Regulations.
    Read more Download 20230208_PR_shares_votingrights_Jan2023.pdf
  • 01/19/2023, Sophia-Antipolis, France

    Median Technologies announces 2022 revenue of €23.8 million, up 16%, and an order backlog of €60.8 million

    Median Technologies announces 2022 revenue of €23.8 million, up 16% vs 2021, an order backlog of €60.8 million and a cash position of €21.5 million as of December 31, 2022.
    Read more Download 20230119_PR_2022KeyPerformance_EN.pdf
  • 01/09/2023, Sophia-Antipolis, France

    Half year liquidity contract statement

    Under the liquidity contract entrusted by Median Technologies (FR0011049824 – ALMDT FP) to TP ICAP (Europe), the following resources were listed in the liquidity account as of 12/31/2022: 22,500 shares, €185,538.38 in cash.
    Read more Download 20230109_PR_liquiditycontract_EN.pdf
  • 01/06/2023, Sophia-Antipolis, France

    Disclosure of total number of voting rights and number of shares in the capital as of December 31st, 2022

    Disclosure of total number of voting rights and number of shares in the capital as of December 31st, 2022, pursuant to article L-223-8 II of the French “code de Commerce” and 223-16 of the AMF’s General Regulations.
    Read more Download 20230106_PR_shares_votingrights_Dec2022.pdf
  • 12/21/2022, Sophia-Antipolis, France

    Financial Communications Schedule for the First Half of 2023

    Median Technologies (ALMDT:PA), announces the publication date for its 2022 results: April 20, 2023 after trading.
    Read more Download 20221221_PR_Schedule_FiCom_H12023.pdf
  • 12/06/2022, Sophia-Antipolis, France

    Disclosure of total number of voting rights and number of shares in the capital as of November 30th, 2022

    Disclosure of total number of voting rights and number of shares in the capital as of November 30th, 2022, pursuant to article L-223-8 II of the French “code de Commerce” and 223-16 of the AMF’s General Regulations.
    Read more Download 20221206_PR_shares_votingrights_Nov2022.pdf
    • 1 … 32